Company

Innovent Biologics Technology

As of the edition of 20 October 2026, Innovent Biologics Technology runs 4 drugs.

Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.

Drugs by status

StatusCount
Active4
Total4

Where its trials are

  • Nutrition and metabolism: 3 trials led
  • Bones, joints and muscles: 1 trials led
  • Inherited and neonatal: 1 trials led